Dr. Laura Graham, is currently leading a phase 2 trial studying whether high doses of testosterone are a feasible treatment against castration-resistant prostate cancer (CRPC) leading to a reduction in prostate cancer growth as well as improved quality of life.
PIKE-PREP offers students from URM communities multi-dimensional mentorship and research training designed to prepare them for enrollment and success in a top-tier PhD or MD/PhD program.
Jessica McDermott, MD, Assistant Professor with the Division of Medical Oncology, has been named Deputy Associate Director for Diversity and Inclusion in Clinical Research. This role was recently created to identify and address barriers clinical trial accrual.
Robert Lentz, MD, spearheads a new phase 2 clinical trial for patients with metastatic colon cancer for whom chemotherapy and biologic therapy are no longer effective options.
Co-director of the hereditary cancer program, Marie Wood, MD, aims to increase patient awareness surrounding the importance of genetic counseling and genetic testing relating to cancer.
Dr. Kabos discusses his recent study analyzing blood plasma to extract critical breast tumor information and disease progression instead of more invasive tissue biopsies.
Dr. Kim discusses why in the United States oncologists have seen the number of new stomach cancer cases decrease over the past decade.
Congratulations to Dr. Erin Schenk who was selected from many highly competitive applications as the 2022 Translational Research Scholars Program Awardee.
Kasey Couts, PhD, has been awarded the Melanoma Research Alliance Young Investigator Award for her research: Targeting anti-tumor immunity in anatomically distinct mucosal melanomas.
Dr. Kabos and his colleagues Paul MacLean, PhD, and Victoria Catenacci, MD, have received an R01 NIH grant to study on the impact of obesity on breast cancer.
Dr. Lam explains why when many cancers are decreasing in incidence, kidney cancer is seeing an increase.
Colon cancer being the third leading cause of cancer deaths in the United States, healthcare providers saw a 90% decrease in colon cancer screenings in 2020. Dr. Sunnie Kim joined the Kathie J Show to stress the importance of regular screenings, while spreading awareness, and providing health tips.